葵花药业：拟投资2000万元设立两家全资子公司

Group 1 - The company, Kew Flower Pharmaceutical (002737), plans to invest a total of 20 million RMB using its own funds to establish two wholly-owned subsidiaries [1] - The two subsidiaries are Kew Flower Pharmaceutical Health Technology Ji'an Co., Ltd. and Kew Flower Pharmaceutical Group (Harbin) Medical Co., Ltd. [1] - Both subsidiaries will have a registered capital of 10 million RMB each, fully owned by Kew Flower Pharmaceutical [1]